logo
Sign in

HMGN Stock Price, Chart, Stats & News

Hemagen Diagnostics, Inc.
Save

Hemagen Diagnostics, Inc. (HMGN) does not currently pay a dividend.

3,100
Market cap
Current P/E
Forward P/E

HMGN chart

1M
3M
1Y
5Y
Loading chart...

About

Health care
Sector
Biotechnology
Industry

Hemagen Diagnostics, Inc., a global biotechnology firm, specializes in delivering clinical diagnostic solutions for both human and animal health. The company designs, manufactures, and distributes the VIRGO product line, a series of human clinical immunoassays used for identifying autoimmune and infectious diseases, as well as acute phase proteins. Its comprehensive human diagnostic portfolio also encompasses Universal IFA components, various supplies, controls, calibrators, accessories, H-rotors, reagents, electrodes, equipment, and specialized assays covering conditions such as Chagas, acute phase proteins, and cytokines.

Similar securities

Based on sector and market capitalization

Report issue